Two different regenerative injections in patients diagnosed with secondary hip osteoarthritis: A report of two cases


Creative Commons License

Say F., Büyükceran İ., Coşkun S.

Journal of Experimental and Clinical Medicine (Turkey), vol.38, no.2, pp.204-207, 2021 (Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.52142/omujecm.38.2.27
  • Journal Name: Journal of Experimental and Clinical Medicine (Turkey)
  • Journal Indexes: Scopus, Academic Search Premier, EMBASE
  • Page Numbers: pp.204-207
  • Keywords: Autologous conditioned serum, Developmental dysplasia of the hip, Platelet rich plasma
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

Non-surgical treatment options are limited in hip osteoarthritis secondary to developmental dysplasia of the hip (DDH). Treatment of Autologous Conditioned Serum (ACS) is based on the high level of anti-inflammatory cytokine production of leukocytes in peripheral blood. It is an effective treatment option which contains the cytokines and the growth factors. Platelet Rich Plasma (PRP) is a form of treatment that stimulates natural healing steps through growth factors in platelets. In this case report we aimed to present the results of ACS and PRP injection in two patients who developed secondary coxarthrosis after DDH surgery. At the 1-year follow-up examination, patient’s functional scores improved and requirement for non-steroid anti-inflammatory drugs had significantly reduced. Regenerative injections either autologous conditioned serum or platelet rich plasma treatments are safe and effective treatments and can be recommended particularly for cases of secondary hip osteoarthritis associated with DDH.